Table GPS-4. Lifetime prevalence of drug use by gender in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) [see all tables in this series...]

Part (v) Lifetime prevalence 15 to 24 years old males: last survey available for each Member State (from 2000 onwards)

Country		Geographical Area	Year	Reference	Age range (15–24)	Sample size (15–24)	Cannabis (%)	Cocaine (%) (1)	Amphetamines (%) (2)	Ecstasy (%) (3)	LSD (%)
Belgium		National	2004	(6)	15–24	:	26.8	:	:	:	:
Bulgaria		National	2008	(3)	15–24	1087	18.7	4.7	6.9	4.8	0.9
Czech Republic		National	2008	(3)	15–24	827	65.7	4.1	9.5	25.0	15.4
Denmark		National	2008	(5)	16–24	879	46.4	15.0	16.5	8.1	1.6
Germany		National	2006	(7)	18–24	1868	44.8	4.4	5.4	6.0	2.6
Estonia		National	2008	(3)	15–24	243	:	:	:	:	:
Ireland		National	2006–07	(5)	15–24	:	29.9	8.9	4.2	8.4	2.0
Greece		National (except Aegean and Ionian Islands)	2004	(3)	15–24	1 785	11.8	0.6	0.4	0.3	0.5
Spain		National	2007-08	(7)	15–24	3943	41.5	11.5	5.2	6.5	:
France		National	2005	(6)	15–24	4662	47.3	2.9	1.1	3.9	1.1
Italy		National	2008	(4)	15–24	3475	37.3	5.5	2.4	3.4	:
Cyprus		National	2006	(1)	15–24	969	11.1	2.8	1.5	3.8	1.3
Latvia		National	2007	(2)	15–24	1855	33.2	5.5	10.7	13.8	4.1
Lithuania		National	2008	(2)	15–24	1165	30.8	1.1	4.8	5.5	0.5
Luxembourg		:	:	:	:	:	:	:	:	:	:
Hungary		National	2007	(3)	18–24	433	30.5	3.4	7.3	8.4	3.4
Malta		National	2001	(1)	18–24	287	:	:	:	:	:
Netherlands		National	2005	(3)	15–24	:	:	:	:	:	:
Austria		National	2008	(2)	15–24	2085	26.1	5.1	5.1	6.4	3.2
Poland		National	2006	(2)	15–24	1135	25.3	1.9	6.0	3.6	2.7
Portugal		National	2007	(2)	15–24	2211	21.0	1.9	1.4	2.9	1.0
Romania		National	2007	(2)	15–24	1060	5.0	0.1	0.1	1.0	0.0
Slovenia		National	2007	(1)	15–24	338	:	:	:	:	:
Slovakia		National	2006	(6)	15–24	287	39.0	4.0	5.3	11.8	:
Finland		National	2006	(7)	15–24	654	20.5	1.6	3.5	2.8	1.2
Sweden		National	2008	(5)	15–24	7787	17.5	1.1	3.8	2.5	:
Sweden		National	2008	(10)	16–24	1166	11.8	:	:	:	:
United Kingdom		England and Wales	2008-09	(12)	16–24	5476	41.6	15.3	12.2	12.3	3.3
United Kingdom		Northern Ireland	2007-08	(16)	16–24	315	32.0	10.5	8.2	12.2	1.9
United Kingdom		Scotland	2006	(19)	16–24	426	53.0	18.8	17.2	18.4	7.1
United Kingdom		United Kingdom	2006	(21)	16–24	:	44.6	13.5	13.0	13.6	4.8
Croatia		:	:	:	:	:	:	:	:	:	:
Turkey		:	:	:	:	:	:	:	:	:	:
Norway		National	2004	(2)	15–24	645	26.5	3.8	5.6	3.2	0.6

Notes:

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy, for Denmark National 1994: hard drugs. 

 (3) For Spain: ecstasy and other designer drugs. 

 Sample sizes refer to the whole age group. Specific sample sizes by gender are not available at the moment but will be collected in the future. 

 This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as reference point for the 1993 survey.  

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups. 

 For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions. 

 For methods of each survey presented in this table, see Table GPS-7 part (i).  

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

                        

Sources:

 See Table GPS-0. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)